Chest
-
COPD PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: To develop and validate a new index to predict mortality, hospital readmission and their combination to 3 and 12 months in patients hospitalized for AECOPD. ⋯ The following authors have nothing to disclose: Jordi Juanola Pla, Pedro Almagro Mena, Joan B Soriano, Francico Cabrera, Ramon Boixeda, Maria Belen Alonso Ortiz, Cristina Murio, Jesus Diez, Bienvenido Barreiro, Josep Lluis HerediaNo Product/Research Disclosure Information.
-
Thoracic Surgery PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: In this study, we have assessed the ability of mesenchymal stromal cells MSCs to differentiate and to contribute in lung repair and how these cells are able to integrate in the initial healing process after a lung parenchyma injury in an animal model. ⋯ The following authors have nothing to disclose: M. Teresa Gómez-Hernández, Maria Rodríguez, Marcelo Fernando Jiménez López, Dolores Ludeña, Begoña García-Cenador, Consuelo CañizoNo Product/Research Disclosure Information.
-
DVT/PE PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Thrombolytic therapy is used for acute pulmonary embolism complicated by shock or cardiopulmonary arrest. Its efficacy is limited by the lack of systemic perfusion required for lysis of the thrombus in the pulmonary vasculature. The only efficacious form of circulatory support may be temporary extracorporeal membrane oxygenator (ECMO) use with venous-arterial cannula. In the absence of ECMO support, prolonged chest compressions after thrombolysis may be required to support the circulation. ⋯ The following authors have nothing to disclose: Carla Nobre, Dinis Mesquita, Boban ThomasNo Product/Research Disclosure Information.
-
COPD Comorbidity PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Comorbidities with COPD (Chronic Obstructive Pulmonary Disease) is one of the most important problems. Previous reports suggested that systemic inflammation may be the link between COPD and comorbidities, but this issue is still low debated in Japan. Whatever the mechanism of comorbidities may be, it has important clinical, prognostic and therapeutic problems. In this study, investigated for the evaluation and measures about COPD burden patients of the current situation in rural area Japan. And also aimed that through comorbidities, contributes to improving patients care and COPD awareness. ⋯ The following authors have nothing to disclose: Tomoyasu UnoNo Product/Research Disclosure Information.
-
Comorbidities of OSA PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: To provide new insight into the expression of TLR2 and TLR4 from OSAHS. ⋯ The following authors have nothing to disclose: Junjun HuangNo Product/Research Disclosure Information.